Botanical species · safety record

Cinchona calisaya

The EFSA Compendium of Botanicals holds 16 constituent measurements for Cinchona calisaya. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cinchona calisaya Wedd.

16Constituent measurements
0Safety records
6Cited sources
1Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Cinchona calisaya as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Bark

What the records describe

Constituents measured

  • Alkaloids5
  • Quinine5
  • Cinchonidine2
  • Cinchonine2
  • Quinidine1
  • Quinoline alkaloids1

Plant parts

  • Bark14
  • Roots and other underground parts1
  • Seed1

Preparations

  • Solvent extraction12
  • Drying (dehydration)4

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsRoots and other underground partsSolvent extraction12.5 Millimole/kilogramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Quinoline alkaloidsBarkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AlkaloidsBarkSolvent extraction≥ 2.25 PercentUnspecifiedNo resolvable identifier
AlkaloidsBarkSolvent extraction9.1 PercentUnspecifiedNo resolvable identifier
AlkaloidsBarkSolvent extraction≤ 4.1 PercentUnspecifiedNo resolvable identifier
AlkaloidsBarkDrying (dehydration)4.5 PercentUnspecifiedNo resolvable identifier
CinchonidineBarkSolvent extraction0.105 PercentUnspecifiedNo resolvable identifier
CinchonidineBarkDrying (dehydration)0.86 PercentUnspecifiedNo resolvable identifier
CinchonineBarkSolvent extraction0.085 PercentUnspecifiedNo resolvable identifier
CinchonineBarkDrying (dehydration)0.26 PercentUnspecifiedNo resolvable identifier
QuinidineBarkSolvent extraction0.08 PercentUnspecifiedNo resolvable identifier
QuinineSeedSolvent extraction0.38 PercentUnspecifiedNo resolvable identifier
QuinineBarkSolvent extraction≤ 2.75 PercentUnspecifiedNo resolvable identifier
QuinineBarkDrying (dehydration)3.38 PercentUnspecifiedNo resolvable identifier
QuinineBarkSolvent extraction≥ 0.961 PercentUnspecifiedNo resolvable identifier
QuinineBarkSolvent extraction7.92 PercentUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. van Lerrsum, P. The occurrence of quinine in the seeds of Cinchona ledgeriana Moens. Pharmaceutisch weekblad, 1914, vol. 50, p. 1464-7.
  2. Wasicky, R., Unti, O., Barbieri, E. Quinine and alkaloids in Brazil. Anais faculdade farm. odontol. univ. sao paulo, 1943, vol. 1942-1943, 3, p. 137-83.
  3. Cheng, Gui-Guang., Zhang, Yu., Cai, Xiang-Hai., Bao, Mei-Fen., Gu, Ji., Li, Yan., Liu, Ning., Liu, Ya-Ping., Luo, Xiao-Dong. Cincholenines A and B, two unprecedented quinoline alkaloids from Cinchona ledgeriana . Tetrahedron letters, 2013, vol. 54, no. 34, p. 4547-4550. DOI
  4. Peterson, Lyall E. Cinchona-the quinine tree. J. forestry, 1947, vol. 45, p. 500-2.
  5. Hodge, W. H. Wartime Cinchona procurement in Latin America. Economic botany, 1948, vol. 2, p. 229-57.
  6. AERTS, RJ., SNOEIJER, W., VANDERMEIJDEN, E., VERPOORTE, R. ALLELOPATHIC INHIBITION OF SEED-GERMINATION BY CINCHONA ALKALOIDS. Phytochemistry, 1991, vol. 30, no. 9, p. 2947-2951. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue